The Latest Breaking News from Matthew Kacsmaryk

The chiefs of more than 400 pharmaceutical companies signed a scathing letter this week blasting federal Judge Matthew Kacsmaryk’s ruling that the Food and Drug Administration had overstepped its authority in approving the abortion-inducing drug mifepristone. The letter was more than justified and, while harshly worded, accurately recounted Kacsmaryk’s abysmal…

The ruling means mifepristone is still available in the U.S., but with several strict limitations.

Moves follow Texas ruling suspending federal approval for abortion pills, state efforts to restrict travel for abortion.

Members of Congress weighed in on a lower court ruling that would stop the manufacture and distribution of an abortion drug.

White House officials are warning that access to nearly any medication is in jeopardy after a federal judge in Texas ordered that a pill commonly used for abortions be pulled off the market

Ukrainian president calls for action after videos circulated online appear to show soldiers beheaded by Russian forces. Plus, Nasa prepares for life on Mars

The toes, the clothes and, oh, the smell of a newborn.

Imagine the reaction if a federal court a few years back had ruled against a controversial White House executive order, and Trump administration officials responded by ignoring the decision. Apoplectic progressives would have taken to the streets to protest the president as an “existential threat to democracy” — and rightfully…

Mifepristone will lose its FDA approval this week unless an appeals court intervenes in a case likely to reach the supreme court